MIF suppresses PAX5 and DMTF1 tumor-suppressor activity and upregulates TAp63 and VLA-4 integrin, collectively enhancing CLL survival and bone marrow tropism [118,119,120]. The gene discussed is MIF; the disease is B-cell chronic lymphocytic leukemia.